FEDERATED HERMES, INC. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2022$6,000
-53.8%
4,901
-51.7%
0.00%
Q1 2022$13,000
+30.0%
10,147
+83.7%
0.00%
Q4 2021$10,0000.0%5,525
+20.0%
0.00%
Q3 2021$10,000
+400.0%
4,603
+941.4%
0.00%
Q2 2021$2,000
-99.8%
442
-99.5%
0.00%
-100.0%
Q3 2020$861,000
-81.9%
83,617
-63.3%
0.00%
-83.3%
Q2 2020$4,754,000
+79133.3%
227,691
+48344.9%
0.01%
Q2 2019$6,0000.0%470
-59.1%
0.00%
Q2 2018$6,000
-14.3%
1,1500.0%0.00%
Q1 2018$7,000
-12.5%
1,150
-52.2%
0.00%
Q4 2017$8,000
+60.0%
2,407
+86.4%
0.00%
Q3 2017$5,0001,2910.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2019
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders